vs

Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and NCR Atleos Corp (NATL). Click either name above to swap in a different company.

NCR Atleos Corp is the larger business by last-quarter revenue ($1.2B vs $829.0M, roughly 1.4× Acadia Healthcare Company, Inc.). NCR Atleos Corp runs the higher net margin — 7.2% vs 0.5%, a 6.7% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 4.0%). Over the past eight quarters, NCR Atleos Corp's revenue compounded faster (4.9% CAGR vs 2.0%).

Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.

NCR Voyix Corporation, previously known as NCR Corporation and National Cash Register, is a global software, consulting and technology company providing several professional services and electronic products. It manufactured self-service kiosks, point-of-sale terminals, automated teller machines, check processing systems, and barcode scanners.

ACHC vs NATL — Head-to-Head

Bigger by revenue
NATL
NATL
1.4× larger
NATL
$1.2B
$829.0M
ACHC
Growing faster (revenue YoY)
ACHC
ACHC
+3.6% gap
ACHC
7.5%
4.0%
NATL
Higher net margin
NATL
NATL
6.7% more per $
NATL
7.2%
0.5%
ACHC
Faster 2-yr revenue CAGR
NATL
NATL
Annualised
NATL
4.9%
2.0%
ACHC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACHC
ACHC
NATL
NATL
Revenue
$829.0M
$1.2B
Net Profit
$4.5M
$83.0M
Gross Margin
Operating Margin
13.5%
Net Margin
0.5%
7.2%
Revenue YoY
7.5%
4.0%
Net Profit YoY
-50.8%
102.4%
EPS (diluted)
$0.05
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACHC
ACHC
NATL
NATL
Q1 26
$829.0M
Q4 25
$821.5M
$1.2B
Q3 25
$851.6M
$1.1B
Q2 25
$869.2M
$1.1B
Q1 25
$770.5M
$979.0M
Q4 24
$774.2M
$1.1B
Q3 24
$815.6M
$1.1B
Q2 24
$796.0M
$1.1B
Net Profit
ACHC
ACHC
NATL
NATL
Q1 26
$4.5M
Q4 25
$-1.2B
$83.0M
Q3 25
$36.2M
$26.0M
Q2 25
$30.1M
$39.0M
Q1 25
$8.4M
$14.0M
Q4 24
$32.6M
$41.0M
Q3 24
$68.1M
$21.0M
Q2 24
$78.5M
$27.0M
Operating Margin
ACHC
ACHC
NATL
NATL
Q1 26
Q4 25
-142.4%
13.5%
Q3 25
4.7%
9.8%
Q2 25
5.8%
10.8%
Q1 25
1.7%
9.5%
Q4 24
4.9%
13.4%
Q3 24
12.1%
10.6%
Q2 24
13.4%
9.8%
Net Margin
ACHC
ACHC
NATL
NATL
Q1 26
0.5%
Q4 25
-143.3%
7.2%
Q3 25
4.3%
2.3%
Q2 25
3.5%
3.5%
Q1 25
1.1%
1.4%
Q4 24
4.2%
3.7%
Q3 24
8.4%
2.0%
Q2 24
9.9%
2.5%
EPS (diluted)
ACHC
ACHC
NATL
NATL
Q1 26
$0.05
Q4 25
$-12.98
$1.09
Q3 25
$0.40
$0.34
Q2 25
$0.33
$0.52
Q1 25
$0.09
$0.19
Q4 24
$0.36
$0.56
Q3 24
$0.74
$0.28
Q2 24
$0.85
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACHC
ACHC
NATL
NATL
Cash + ST InvestmentsLiquidity on hand
$158.5M
$456.0M
Total DebtLower is stronger
$2.5B
$2.7B
Stockholders' EquityBook value
$2.0B
$403.0M
Total Assets
$5.5B
$5.7B
Debt / EquityLower = less leverage
1.29×
6.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACHC
ACHC
NATL
NATL
Q1 26
$158.5M
Q4 25
$133.2M
$456.0M
Q3 25
$118.7M
$412.0M
Q2 25
$131.4M
$357.0M
Q1 25
$91.2M
$352.0M
Q4 24
$76.3M
$419.0M
Q3 24
$82.1M
$395.0M
Q2 24
$77.2M
$374.0M
Total Debt
ACHC
ACHC
NATL
NATL
Q1 26
$2.5B
Q4 25
$2.5B
$2.7B
Q3 25
$2.3B
$2.8B
Q2 25
$2.3B
$2.8B
Q1 25
$2.2B
Q4 24
$2.0B
$2.9B
Q3 24
$1.9B
Q2 24
$1.8B
Stockholders' Equity
ACHC
ACHC
NATL
NATL
Q1 26
$2.0B
Q4 25
$1.9B
$403.0M
Q3 25
$3.1B
$330.0M
Q2 25
$3.1B
$350.0M
Q1 25
$3.0B
$275.0M
Q4 24
$3.1B
$219.0M
Q3 24
$3.0B
$264.0M
Q2 24
$3.0B
$250.0M
Total Assets
ACHC
ACHC
NATL
NATL
Q1 26
$5.5B
Q4 25
$5.5B
$5.7B
Q3 25
$6.4B
$5.7B
Q2 25
$6.3B
$5.8B
Q1 25
$6.1B
$5.7B
Q4 24
$6.0B
$5.5B
Q3 24
$5.9B
$5.7B
Q2 24
$5.7B
$5.8B
Debt / Equity
ACHC
ACHC
NATL
NATL
Q1 26
1.29×
Q4 25
1.28×
6.63×
Q3 25
0.74×
8.45×
Q2 25
0.74×
8.05×
Q1 25
0.72×
Q4 24
0.64×
13.05×
Q3 24
0.62×
Q2 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACHC
ACHC
NATL
NATL
Operating Cash FlowLast quarter
$61.5M
$231.0M
Free Cash FlowOCF − Capex
$194.0M
FCF MarginFCF / Revenue
16.8%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
13.78×
2.78×
TTM Free Cash FlowTrailing 4 quarters
$239.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACHC
ACHC
NATL
NATL
Q1 26
$61.5M
Q4 25
$-86.3M
$231.0M
Q3 25
$73.2M
$25.0M
Q2 25
$133.5M
$-23.0M
Q1 25
$11.5M
$123.0M
Q4 24
$116.7M
$80.0M
Q3 24
$163.1M
$107.0M
Q2 24
$171.1M
$9.0M
Free Cash Flow
ACHC
ACHC
NATL
NATL
Q1 26
Q4 25
$-179.5M
$194.0M
Q3 25
$-63.0M
$-5.0M
Q2 25
$-34.2M
$-44.0M
Q1 25
$-163.2M
$94.0M
Q4 24
$-86.8M
$62.0M
Q3 24
$-27.1M
$85.0M
Q2 24
$16.9M
$-14.0M
FCF Margin
ACHC
ACHC
NATL
NATL
Q1 26
Q4 25
-21.8%
16.8%
Q3 25
-7.4%
-0.4%
Q2 25
-3.9%
-4.0%
Q1 25
-21.2%
9.6%
Q4 24
-11.2%
5.6%
Q3 24
-3.3%
7.9%
Q2 24
2.1%
-1.3%
Capex Intensity
ACHC
ACHC
NATL
NATL
Q1 26
Q4 25
11.3%
3.2%
Q3 25
16.0%
2.7%
Q2 25
19.3%
1.9%
Q1 25
22.7%
3.0%
Q4 24
26.3%
1.6%
Q3 24
23.3%
2.1%
Q2 24
19.4%
2.1%
Cash Conversion
ACHC
ACHC
NATL
NATL
Q1 26
13.78×
Q4 25
2.78×
Q3 25
2.02×
0.96×
Q2 25
4.43×
-0.59×
Q1 25
1.37×
8.79×
Q4 24
3.58×
1.95×
Q3 24
2.39×
5.10×
Q2 24
2.18×
0.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACHC
ACHC

Acute Inpatient Psychiatric Facilities$471.0M57%
Other$140.0M17%
Specialty Treatment Facilities$128.0M15%
Residential Treatment Facilities$90.0M11%

NATL
NATL

Services$848.0M74%
APJ$136.0M12%
Americas Excluding United States$135.0M12%
TT$44.0M4%

Related Comparisons